An official website of the United States government
NIH Guide: Weekly Index for April 22, 2022
Weekly NIH Funding Opportunities and Notices
April 22, 2022
General Notices
-
Notice of Pre-application Webinar for NCI Funding Opportunity Announcements for Cancer Epidemiology Cohorts (PAR-22-161, PAR-22-162)
(NOT-CA-22-081)National Cancer Institute
-
Notice of NCI's participation on PAR-22-145, "Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional)"
(NOT-CA-22-082)National Cancer Institute
-
Notice of Pre-Application Technical Assistance Webinar for RFA-MD-22-008, Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 - Clinical Trials Optional)
(NOT-MD-22-016)National Institute on Minority Health and Health DisparitiesNational Cancer Institute
-
Findings of Research Misconduct
(NOT-OD-22-115)Office of the Director, NIH
-
Notice of Correction to RFA-OD-22-004, "Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional)"
(NOT-OD-22-116)Office of Disease Prevention
-
Request for Information (RFI) on Flexibilities for Conducting Semiannual Animal Program Review
(NOT-OD-22-114)Office of the Director, NIH
Notice of Changes to Funding Opportunities
-
Notice of NIAAA Withdrawal from Participation in PAR-20-279 "Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional)"
(NOT-AA-22-013)National Institute on Alcohol Abuse and Alcoholism
-
Notice of Change to section for PAR-21-320, "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)"
(NOT-DA-22-055)National Institute on Drug Abuse
-
Notice of Extension of Application Due Date and Award Budget Information for RFA-DK-21-505, Limited Competition for the Continuation of the Data Coordinating Center for the Diabetic Foot Consortium (U24 Clinical Trial Optional)
(NOT-DK-22-021)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Correction to PAR-22-145: Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional) to address changes to the Funding Opportunity Description and Agency Contacts
(NOT-MD-22-017)National Institute on Minority Health and Health Disparities
-
Notice of Early Termination of RFA-NS-21-015 "HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development (U19 Clinical Trial Not Allowed)
(NOT-NS-22-049)National Institute of Neurological Disorders and StrokeNational Institute on AgingNational Center for Complementary and Integrative Health
Notices of Special Interest
-
Notice of Special Interest (NOSI) - Administrative Supplements for Research of Emerging and Existing Issues of COVID-19 Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities
(NOT-HD-22-003)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute on Alcohol Abuse and AlcoholismNational Institute on Drug AbuseNational Institute of Neurological Disorders and StrokeOffice of Research on Women's HealthOffice of Behavioral and Social Sciences Research
-
Notice of Special Interest (NOSI): Availability of Administrative Supplements for Helping to End Addiction Long-term (HEAL) Initiative awardees to make data Findable, Accessible, Interoperable, and Reusable (FAIR) through the HEAL Data Ecosystem
(NOT-OD-22-110)Office of the Director, NIHNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeNational Center for Advancing Translational SciencesNational Center for Complementary and Integrative HealthNational Center for Advancing Translational Sciences
Funding Opportunities
-
NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)
(PAR-22-142)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Multiple dates, see announcement.
-
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)
(PAR-22-151)John E. Fogarty International CenterNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Mental HealthOffice of Research on Women's HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71 Clinical Trial Not Allowed)
(PAR-22-152)John E. Fogarty International CenterNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Mental HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed)
(PAR-22-153)John E. Fogarty International CenterNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchApplication Receipt Date(s): Multiple dates, see announcement.
-
Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
(PAR-22-163)National Institute of General Medical SciencesApplication Receipt Date(s): September 27, 2022
-
Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30 - Clinical Trial Not Allowed)
(PAR-22-166)National Institute of General Medical SciencesApplication Receipt Date(s): October 10, 2024
-
Demonstration Projects to Promote Use of Interoperable Health Records in Clinical Research (R01 Clinical Trial Not Allowed)
(RFA-AG-23-019)National Institute on AgingApplication Receipt Date(s): October 18, 2022
-
Neuronal Vulnerability to Proteinopathies in Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Not Allowed)
(RFA-AG-23-028)National Institute on AgingApplication Receipt Date(s): July 15, 2022
-
HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)
(RFA-NS-22-052)National Institute of Neurological Disorders and StrokeNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute of Dental and Craniofacial ResearchNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Center for Complementary and Integrative HealthApplication Receipt Date(s): Multiple dates, see announcement.
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: March 27, 2025
For technical issues E-mail OER Webmaster